DJ IVD Medical May Continue Gaining Market Share in Hospitals -- Market Talk
0748 GMT - IVD Medical, which is the sole distributor for Sysmex hemostasis IVD products in China, may continue gaining market share in hospitals, Jefferies says. Jefferies initiates coverage on the stock with a buy rating and a target price of HK$5.00. IVD Medical already covers six out of eight IVD segments in China, the U.S. investment bank adds. The medical supplier may also start to expand its profit margins as it starts to increase the breadth of its product offerings, including its self-branded products, the bank says. Shares gain 3.2% to HK$2.92. (yiwei.wong@wsj.com)
(END) Dow Jones Newswires
July 23, 2020 03:48 ET (07:48 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
DJ IVD Medical可能繼續擴大醫院市場份額--市場談話
0748GMT-Jefferies表示，作為Sysmex止血IVD產品在中國的獨家分銷商，IVD Medical可能會繼續獲得醫院的市場份額。傑富瑞以買入評級及目標價5.00港元對該股發起覆蓋。這家美國投資銀行補充説，IVD Medical已經覆蓋了中國八個IVD細分市場中的六個。世行表示，這家醫療供應商也可能開始擴大利潤率，因為它開始增加產品供應的廣度，包括自有品牌的產品。該公司股價上漲3.2%，至2.92港元。(yi wei.wong@wsj.com)
(完)道瓊斯通訊社
2020年7月23日東部時間03：48(格林尼治標準時間07：48)
版權所有(C)2020道瓊斯公司。
使用瀏覽器的分享功能，分享給你的好友吧